X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/novel-t-cell-engager-cdh17-x-cd3-cabotamig-arb202-continues-to-explore-dosing-in-patients-with-advanced-gastrointestinal-cancers-302128499.html
https://www.prnewswire.com/news-releases/arbele-announces-early-safety-data-for-novel-cdh17xcd3-bispecific-t-cell-engager-at-american-society-of-clinical-oncology-breakthrough-meeting-301891273.html